In focus
Latest feed
The Long Road to Healing: Why Sickle Cell Disease Still Demands Better, Accessible Treatments
AI's New Frontier: Revolutionizing Rare Disease Diagnosis and Care
A Bold New Chapter: Rare Ventures Launches with a $25 Million Bet on a Smarter Approach to Rare Disease Therapies
Rare Disease Makers Push Back on Medicare Price‑Cut Pilots
